Fundz

Who to call at Hansoh Pharma, and when

Fundz watches for the moments Hansoh Pharma starts buying, and tells you who to reach.

  • An alert the day Hansoh Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Hansoh Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Hansoh Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Hansoh Pharma and Roche Expand Partnership with $15 Billion Agreement for ADC Programs.

Oct 19, 2026

Contract Type

agreement

BiotechnologyHealth CarePharmaceuticalBiopharma

Description

Hansoh Pharma has entered into a $15 billion collaboration and license agreement with Roche, enhancing their partnership in the ADC field. This agreement covers two preclinical ADC programs and additional initiatives, with Hansoh leading early development before Roche takes over globally.

Quick answer

Hansoh Pharma and Roche Expand Partnership with $15 Billion Agreement for ADC Programs. (October 19, 2026).

What agreement did Hansoh Pharma announce on October 19, 2026?
Hansoh Pharma has entered into a $15 billion collaboration and license agreement with Roche, enhancing their partnership in the ADC field. This agreement covers two preclinical ADC programs and additional initiatives, with Hansoh leading early development before Roche takes over globally.
What does Hansoh Pharma do?
Hansoh Pharma is a leading biopharmaceutical company that focuses on the research and development of innovative drugs.
Which similar companies announced agreements around the same time?
AbbVie Inc. (November 3, 2026), Sino Biopharmaceutical (November 13, 2026), Pfizer (November 14, 2026) and YD Bio Limited (October 20, 2026) also announced agreements within 45 days of Hansoh Pharma.

Source: Fundz verified event record.

Other recent agreements in Pharmaceutical and Biopharma

Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.

Company Information

Company

Hansoh Pharma

About

Hansoh Pharma is a leading biopharmaceutical company that focuses on the research and development of innovative drugs. The company is committed to providing high-quality medicines that address unmet medical needs. Specializing in oncology, Hansoh actively collaborates with global partners to enhance drug development capabilities.

Predictive Intelligence
Strategic

ML-powered predictions for Hansoh Pharma's next move

Learn about Strategic plan

Hansoh Pharma signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.